Vaccination against rubella in Britain: benefits and risks.

  • David Freestone
  • Published 1979 in Developments in biological standardization


The benefits and risks of rubella vaccine differ with the programme of vaccination adopted. Programmes in which vaccine is primarily administered to girls aged 11 to 13 years are slow in achieving effects on the incidence of congenital rubella because of the 10 year delay between vaccination and peak child-bearing. In Britain an increase in the percentage… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics